| Table 1: | |||
|
Prevalence
of Major Hypercoagulable States in Different Patient Populations
|
|||
|
Hypercoagulable
State |
General
Population (%) |
Patients
with
Single VTE (%) |
Thrombophilic
Families (%) |
| Factor V Leiden |
3-7
|
20
|
50
|
| Prothrombin G20210A |
1-3
|
6
|
18
|
| Antithrombin deficiency |
0.02
|
1
|
4-8
|
| Protein C deficiency |
0.2-0.4
|
3
|
6-8
|
| Protein S deficiency |
N/A
|
1-2
|
3-13
|
|
|
|||
| Hyperhomocysteinemia |
5-10
|
10-25
|
N/A
|
| Antiphospholipid antibodies |
0-7
|
5-15
|
N/A
|
| N/A=not readily available or unknown. | |||
|
Copyright
2003 The Cleveland Clinic Foundation
|
Return to Hypercoagulable States Chapter